An Act To Institute Testing And Tracking Of Medical Use Cannabis And Cannabis Products Similar To Adult Use Cannabis And Cannabis Products, Dedicate A Portion Of The Adult Use Cannabis Sales And Excise Tax To Medical Use Cannabis Programs And Create A Study Group

This bill requires medical cannabis dispensaries and caregivers to test all cannabis products before selling them to patients, ensuring they meet safety standards for contaminants like pesticides, microbes, and THC potency (max 10mg per serving, with a 10% variance allowance). It mandates testing for harmful substances including pesticides, molds, and PFAS, and requires detailed record-keeping of test results. The bill also directs a portion of adult-use cannabis tax revenue to fund medical cannabis programs and creates a study group to review the program’s effectiveness. These changes directly affect medical cannabis patients, dispensaries, and caregivers in Maine by aligning safety protocols with adult-use standards.